Currently, in medicine, steel and titanium, which are non-degradable in the environment of the human body, are mainly used as materials for creating orthopedic implants and products for cardiovascular surgery. These materials have proven themselves well in this direction, but they have one significant drawback – the need for repeated surgery to remove a worn-out structure. Otherwise, the products in the patient's body can cause negative reactions of the body due to the gradual release of metal ions. In addition, the mechanical properties of steel and titanium implants significantly exceed the properties of cortical bone, which can cause uneven bone remodeling. Therefore, currently, doctors and materials scientists have taken care of creating a new generation of implants that would have the ability to bioresorption, that is, decompose in the patient's body during the healing process of injury. Promising candidates for the creation of such products are alloys based on Mg, Zn and Fe-Mn systems. The advantage of products made from these materials is that after completion of therapy (after fusion of the fracture, release of the drug, resorption of cholesterol deposits), there is no need to remove the product from the patient's body, since it gradually dissolves and is excreted from the body naturally. The use of bioresorbable implants reduces the risk of peri-implantation osteoporosis due to the so-called stress screening effect, reduces the risk of complications in the patient, reduces the likelihood of allergic reactions, and due to gradual degradation also allows for the gradual flow of medicines (for example, an antibiotic or cytostatic) into the implantation area. In addition, such implants are of particular interest in the treatment of bone fractures in children and adolescents, since they have constant bone growth, which makes it difficult to use non-resorbable implants. The Laboratory of Metallology of Non-ferrous and Light Metals conducts research on all three promising metals.